Liposomes (a Review): Part Two, Drug Delivery Systems

Suggy S. Chrai;R. Murari;Imran Ahmad;

Publication

Article

January 15, 2002

BioPharm International

BioPharm International-01-01-2002

Volume15

Issue 1

Liposomes (a Review): Part Two, Drug Delivery Systems

Author(s):

Suggy S. Chrai,R. Murari

by Suggy S. Chrai, R. Murari, and Imran Ahmad Good manufacturing processes require that lipid vesicles be reproducibly uniform in size, carry the drug in sufficient concentration, and remain stable for an acceptable shelf-life under varying temperatures. Following these guidelines improves the analytical processes that support biopharmaceutical drug development.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Outsourcing Outlook: E-Sourcing, Internet Facilitates Flexible Collaboration

Inside Washington: Biotechnology in the Limelight, the Year Ahead

Your Vested Interests: The War of the West

Statistics for Laboratory Method Comparison Studies

From the Editor: Farewell to 2001 . . . Our Biotech Odyssey Continues

Systematic Troubleshooting for LC/MS/MS: Part 2, Large-Scale LC/MS/MS and Automation

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!